Immune reconstitution complicated by CMV retinitis in a pediatric patient who underwent haploidentical CD34+-selected hematopoietic stem cell transplant for acute lymphoblastic leukemia

International Journal of Hematology

Volumn 88, Issue 2, 2008, Pages 145-148

  Cesaro, Simone ^a   Boaro, Maria Paola ^a   Pillon, Marta ^a   Calore, Elisabetta ^a   Cermakova, Ivete ^a   Perruccio, Katia ^b   Mengoli, Carlo ^a   Messina, Chiara ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Children; Cytomegalovirus retinitis; Haploidentical hematopoietic stem cell transplantation

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR; VALGANCICLOVIR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CD34 SELECTION; CLONE; CONVALESCENCE; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENERAL CONDITION IMPROVEMENT; GRAFT INFECTION; GRAFT RECIPIENT; HAPLOIDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; LIVING DONOR; MALE; OPHTHALMOSCOPY; RELAPSE; RETINITIS; SCREENING TEST; THERAPY EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VIRUS REACTIVATION; VISUAL ACUITY;

ADOLESCENT; ADOPTIVE TRANSFER; ANTIGENS, CD34; CYTOMEGALOVIRUS INFECTIONS; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, T-CELL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECOVERY OF FUNCTION; RETINITIS;

EID: 56649088241     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0126-z     Document Type: Article

References (19)

1. DA Jabs ML Van Natta JH Kempen 2002 Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy Am J Ophthalmol 133 48 61
2. Lin Dy JF Warren LC Lazzeroni RA Wolitz SE Mansour 2002 Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors Retina 22 268 77
3. GN Nichols M Boeckh 2000 Recent advances in the therapy and prevention of CMV infections J Clin Virol 16 25 40
4. H Chung KH Kim JG Kim SY Lee YH Yoon 2007 Retinal complications in patients with solid organ or bone marrow transplantations Transplantation 83 694 9
5. F Crippa L Corey EL Chuang G Sale M Boeckh 2001 Virological, clinical and ophthalmogic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation Clin Infect Dis 32 214 9
6. K Larsson B Lonnqvist O Ringden B Hedquist P Ljungman 2002 CMV retinitis after allogeneic bone marrow transplantation: a report of five cases Transpl Infect Dis 4 75 9
7. A Xhaard M Robin C Scieux 2007 Increased incidence of cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation Transplantation 83 80 3
8. H Miyoshi K Tanaka-Taya Y Nagae 1998 Cytomegalovirus retinitis after transplantation of positively selected CD 34+ cells from HLA mismatched donors Ped Infect Dis J 17 345 8
9. T Miyamoto H Gondo Y Miyoshi 1998 Early viral complications following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma Br J Haematol 100 348 50
10. H Ohta Y Matsuda S Tokimasa 2001 Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis after stem cell transplantation: effective monitoring of CMV infection by quantitative analysis of CMV mRNA Bone Marrow Transplant 27 1141 5
11. F Aversa A Tabilio A Velardi 2007 Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option Curr Stem Cell Res Ther 2 105 12
12. F Aversa A Terenzi A Tabilio 2005 Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse J Clin Oncol 23 3447 54
13. M Boeckh TA Gooley D Myerson T Cunnigham G Schonch RA Bowden 1996 Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study Blood 88 4063 71
14. P Reusser H Einsele J Lee 2002 Infectious diseases working party of the European group for blood and marrow transplantation. Randomized multicenter trial of foscarnet versus ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation Blood 99 4 1159 64
15. K Perruccio A Tosti E Burichelli 2005 et al. Transferring functional immune response to pathogens after haploidentical haematopoietic transplantation Blood 106 13 4397 406
16. N Suzuki T Kudoh N Mizue 1998 CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in a unrelated BMT recipient Bone Marrow Transplant 22 931 2
17. K Kuriyama S Todo S Ikishima 2001 Risk factors for cytomegalovirus retinitis following bone marrow transplantation from unrelated donors in patients with severe aplastic anemia or myelodisplasia Int J Hematol 74 455 60
18. F Ghosh LJ Hansson G Bynke A Bekassy 2002 Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation Acte Ophthalmol Scand 80 101 4
19. H Einsele M Kapp GU Grigoleit 2008 CMV-specific T cell therapy Bllod Cells Mol Dis 40 71 5